AHMEDABAD, India , January 10, 2017 /PRNewswire/ -- Intas Pharmaceuticals Completes Deal to A cquire Actavis UK & Ireland Generics Businesses F rom Teva Intas Pharmaceuticals Ltd. ('Intas'), through its wholly-owned ...
NEW YORK , Jan. 9, 2017 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq: IMNP) ("Immune"), announced today that it intends to request a hearing before the Nasdaq Listing Qualifications Staff Panel to appeal a notification that Immune's ...
LONDON , Jan. 9, 2017 /PRNewswire/ -- Use this report to: - Analyze the global market for antithrombotic/anticoagulant drugs and the different segments for treating thrombotic disease.- View competitive analyses of recent developments and ...
Includes 3 FREE quarterly updates LONDON , Jan. 9, 2017 /PRNewswire/ -- A significant increase in Ireland's 2017 health budget will support the increasing demand for medical treatment. However, cost control measures targeting ...
TUCSON, Ariz. , Jan. 9, 2017 /PRNewswire-USNewswire/ -- While Republicans in Congress argue over repealing or replacing or delaying on the Affordable Care Act (ACA or "ObamaCare"), the Association of American Physicians and Surgeons (AAPS) ...
- Marketing Authorization Application is expected to be filed in mid-2017 PK Parameter Geometric Mean (Test/Reference *100%) 90% Confidence Interval ...
Award Supports Development Through Phase 2a Clinical Trials SAN JOSE, Calif. , Jan. 9, 2017 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. , a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and ...
First Study to Explore Adherence Patterns in Concurrent Use of Medications for COPD and Other Chronic Diseases LOUISVILLE, Ky. and RIDGEFIELD, Conn. , Jan. 9, 2017 /PRNewswire/ -- Humana Inc. (NYSE: HUM), one of the country's leading ...
MVT-1075 Combines the Company's HuMab-5B1 Antibody with the Radiopharmaceutical (177)Lutetium to Treat Pancreatic Cancer. Patient Enrollment in Trial Expected to Begin in Early 2017 SAN DIEGO , Jan. 9, 2017 /PRNewswire/ -- MabVax ...
HONG KONG , Jan. 9, 2017 /PRNewswire-USNewswire/ -- Ascentage Pharma, a global, clinical-stage biopharmaceutical company focused on apoptosis-targeted oncology drug discovery and development, today announced the completion of its Series B ...
Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...
The efficacy of mRNA vaccine technology demonstrated during the COVID-19 pandemic provides optimism for its utilization in mitigating preventable illnesses across various disease domains ( ). ...
An intradermal monkeypox (Mpox) vaccination regimen with reduced dosage proved safe and elicited an antibody response comparable to the standard regimen at six weeks (two weeks post-second dose). ...
The World Health Organization (WHO) granted prequalification to a novel oral cholera vaccine on April 12. The Euvichol-S oral vaccine, which is inactivated, demonstrates comparable effectiveness to the current vaccines, ...
Alectinib, a molecule developed by Genentech, Inc has been granted approval by the Food and Drug Administration on April 18, 2024, for the adjuvant treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers